Literature DB >> 1400988

Cell-mediated and humoral immune responses induced by scarification vaccination of human volunteers with a new lot of the live vaccine strain of Francisella tularensis.

D M Waag1, A Galloway, G Sandstrom, C R Bolt, M J England, G O Nelson, J C Williams.   

Abstract

Tularemia is a disease caused by the facultative intracellular bacterium Francisella tularensis. We evaluated a new lot of live F. tularensis vaccine for its immunogenicity in human volunteers. Scarification vaccination induced humoral and cell-mediated immune responses. Indications of a positive immune response after vaccination included an increase in specific antibody levels, which were measured by enzyme-linked immunosorbent and immunoblot assays, and the ability of peripheral blood lymphocytes to respond to whole F. tularensis bacteria as recall antigens. Vaccination caused a significant rise (P less than 0.05) in immunoglobulin A (IgA), IgG, and IgM titers. Lymphocyte stimulation indices were significantly increased (P less than 0.01) in vaccinees 14 days after vaccination. These data verify that this new lot of live F. tularensis vaccine is immunogenic.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1400988      PMCID: PMC265488          DOI: 10.1128/jcm.30.9.2256-2264.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Soviet viable Pasteurella tularensis vaccines. A review of selected articles.

Authors:  W D TIGERTT
Journal:  Bacteriol Rev       Date:  1962-09

2.  Laboratory-acquired tularemia in vaccinated individuals: a report of 62 cases.

Authors:  T E VAN METRE; P J KADULL
Journal:  Ann Intern Med       Date:  1959-03       Impact factor: 25.391

3.  AEROSOL INFECTION OF MAN WITH PASTEURELLA TULARENSIS.

Authors:  F R McCrumb
Journal:  Bacteriol Rev       Date:  1961-09

4.  Studies on tularemia. V. Immunization of man.

Authors:  P J KADULL; H R REAMES; L L CORIELL; L FOSHAY
Journal:  J Immunol       Date:  1950-10       Impact factor: 5.422

5.  Agglutination and ELISA methods in the diagnosis of tularemia in different clinical forms and severities of the disease.

Authors:  H Syrjälä; P Koskela; T Ripatti; A Salminen; E Herva
Journal:  J Infect Dis       Date:  1986-01       Impact factor: 5.226

6.  A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum.

Authors:  M A Markwell
Journal:  Anal Biochem       Date:  1982-09-15       Impact factor: 3.365

7.  Vaccine potencies of the live vaccine strain of Francisella tularensis and isolated bacterial components.

Authors:  P Hambleton; C G Evans; A M Hood; R E Strange
Journal:  Br J Exp Pathol       Date:  1974-08

8.  Tularaemia in the rat. I. The cellular basis on host resistance to infection.

Authors:  A A Kostiala; D D McGregor; P S Logie
Journal:  Immunology       Date:  1975-05       Impact factor: 7.397

9.  Immunospecific T-lymphocyte stimulation by membrane proteins from Francisella tularensis.

Authors:  G Sandström; A Tärnvik; H Wolf-Watz
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

10.  The immune response to phase I and phase II Coxiella burnetii antigens as measured by western immunoblotting.

Authors:  J M Blondeau; J C Williams; T J Marrie
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

View more
  11 in total

1.  Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strains.

Authors:  Gopi Mara-Koosham; Julie A Hutt; C Rick Lyons; Terry H Wu
Journal:  Infect Immun       Date:  2011-01-31       Impact factor: 3.441

2.  Formulation and stabilization of Francisella tularensis live vaccine strain.

Authors:  Satoshi Ohtake; Russell A Martin; Atul Saxena; David Lechuga-Ballesteros; Araceli E Santiago; Eileen M Barry; Vu Truong-Le
Journal:  J Pharm Sci       Date:  2011-04-13       Impact factor: 3.534

3.  Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis.

Authors:  D M Waag; K T McKee; G Sandstrom; L L Pratt; C R Bolt; M J England; G O Nelson; J C Williams
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

4.  Rapid method for detection of Coxiella burnetii antibodies using high-density particle agglutination.

Authors:  S V Nguyen; H Otsuka; G Q Zhang; H To; T Yamaguchi; H Fukushi; A Noma; K Hirai
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

5.  Differential requirements for protection against mucosal challenge with Francisella tularensis in the presence versus absence of cholera toxin B and inactivated F. tularensis.

Authors:  Constantine Bitsaktsis; Deepak B Rawool; Ying Li; Nitin V Kurkure; Bibiana Iglesias; Edmund J Gosselin
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

6.  An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes.

Authors:  Marcela F Pasetti; Lilian Cuberos; Thomas L Horn; Jeffry D Shearer; Stephen J Matthews; Robert V House; Marcelo B Sztein
Journal:  Vaccine       Date:  2008-01-29       Impact factor: 3.641

7.  Evaluation of specificity of indirect enzyme-linked immunosorbent assay for diagnosis of human Q fever.

Authors:  I J Uhaa; D B Fishbein; J G Olson; C C Rives; D M Waag; J C Williams
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

8.  Comparative analysis of antibodies to Francisella tularensis antigens during the acute phase of tularemia and eight years later.

Authors:  L Bevanger; J A Maeland; A I Kvan
Journal:  Clin Diagn Lab Immunol       Date:  1994-03

9.  Transcriptome analysis of human immune responses following live vaccine strain (LVS) Francisella tularensis vaccination.

Authors:  Claudette L Fuller; Katherine C Brittingham; Mark W Porter; Matthew J Hepburn; Patricia L Petitt; Phillip R Pittman; Sina Bavari
Journal:  Mol Immunol       Date:  2007-03-08       Impact factor: 4.407

Review 10.  Francisella tularensis, Tularemia and Serological Diagnosis.

Authors:  Max Maurin
Journal:  Front Cell Infect Microbiol       Date:  2020-10-26       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.